Diary - News All news ERYTECH Enters Into Strategic Supply Partnership

ERYTECH Enters Into Strategic Supply Partnership

ERYTECH Enters Into Strategic Supply Partnership with the German Red Cross Blood Donor Service

Second European source of donor red blood cells secured in preparation for expanded production of red blood cell-based therapeutics

Lyon (France) and Cambridge, MA (U.S.), February 20, 2020 – ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced that it has entered into a strategic partnership with the German Red Cross Blood Donor Service Baden-Württemberg-Hessen (GRCBDS) to complement the existing alliance with the French Blood bank (EFS) for the supply of donor red blood cells to manufacture its product candidates, including eryaspase, in Europe.